Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers.

Date publication

juillet 2024

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Dr BOUVIER Anne-Marie , Dr JOOSTE Valérie , Pr LEPAGE Côme

Tous les auteurs :
Botta L, Capocaccia R, Bernasconi A, Rossi S, Galceran J, Maso LD, Lepage C, Molinié F, Bouvier AM, Marcos-Gragera R, Vener C, Guevara M, Murray D, Ragusa R, Gatta G, Jooste V,

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39013266

Résumé

To estimate net survival and cancer cure fraction (CF), i.e. the proportion of patients no longer at risk of dying from cancer progression/relapse, a clear distinction needs to be made between mortality from cancer and from other causes. Conventionally, CF is estimated assuming no excess mortality compared to the general population.

Mots clés

Breast cancer, Colorectal cancer, Cure fraction, Head and neck cancer, Increased risk of non-cancer mortality, Mixture cure model, Population based cancer registry

Référence

Eur J Cancer. 2024 07 9;208:114187